Pharmaceutical manufacturer specializing in generic, brand and biosimilar products.
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2020 | THE D MAJOR GROUP |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Termination |
— | |
| 2020 | THE D MAJOR GROUP |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— |
| Firm | Filings | Expenses |
|---|---|---|
| THE D MAJOR GROUP | 28 | — |
| Issue | Activities |
|---|---|
| Copyright/Patent/Trademark | 25 |
| Health Issues | 23 |
| Budget/Appropriations | 17 |
| Pharmacy | 7 |
| Taxation/Internal Revenue Code | 7 |
| Medicare/Medicaid | 4 |
| Medical/Disease Research/Clinical Labs | 1 |